FIBROGEN INC Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fibrogen Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Fibrogen Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$10.9M, a 87.6% increase year-over-year.
  • Fibrogen Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$160M, a 50.7% increase year-over-year.
  • Fibrogen Inc annual Operating Income (Loss) for 2023 was -$282M, a 6.38% increase from 2022.
  • Fibrogen Inc annual Operating Income (Loss) for 2022 was -$301M, a 4.33% decline from 2021.
  • Fibrogen Inc annual Operating Income (Loss) for 2021 was -$289M, a 50.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$282M +$19.2M +6.38% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$301M -$12.5M -4.33% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$289M -$96.7M -50.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$192M -$103M -115% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$89.3M -$2.62M -3.02% Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
2018 -$86.7M +$30.6M +26.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$117M -$67.2M -134% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$50M +$27.6M +35.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$77.6M -$27.5M -54.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$50.1M -$42.2M -530% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$7.95M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.